Clorox CEO Rendle acquires 29,352 grant shares

The reported entries separate a deferred performance-unit settlement from two tax-withholding transactions tied to vesting.

Rhea-AI Filing Summary

Clorox chief executive officer and director Linda J. Rendle acquired 29,352 common shares through settlement of a 2023 Performance Unit Grant that vested October 5, 2026; she elected to defer the settlement under the 2005 Stock Incentive Plan. On that date, Clorox withheld 692 shares for taxes relating to vesting performance stock units and 11,989 shares for taxes relating to vesting restricted stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Rendle Linda J

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	29,352	$80.41	$2.36M
Tax Withholding	Common Stock F2	692	$80.41	$56K
Tax Withholding	Common Stock F3, F4	11,989	$80.41	$964K

Holdings After Transaction: Common Stock — 269,807 shares (Direct)

Footnotes (4)

1. F1. Settlement of 2023 Performance Unit Grant that vested 10/5/26, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.
2. F2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.
3. F3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
4. F4. Includes 3679 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

Key Figures

Performance Unit Grant shares acquired: 29,352 shares Shares withheld for performance stock unit taxes: 692 shares Shares withheld for restricted stock taxes: 11,989 shares +1 more

4 metrics

Performance Unit Grant shares acquired 29,352 shares Settlement of the grant that vested October 5, 2026

Shares withheld for performance stock unit taxes 692 shares October 5, 2026

Shares withheld for restricted stock taxes 11,989 shares October 5, 2026

Reported price per share $80.41 per share Reported for the October 5, 2026 transactions

Key Terms

Performance Unit Grant, restricted stock, dividend reinvestment feature

3 terms

Performance Unit Grant financial

"Settlement of 2023 Performance Unit Grant"

restricted stock financial

"tax obligations relating to vesting of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

dividend reinvestment feature financial

"dividend reinvestment feature of the Company's Stock Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did CLX CEO Linda J. Rendle acquire?

Linda J. Rendle acquired 29,352 common shares through settlement of a 2023 Performance Unit Grant that vested October 5, 2026. She elected to defer the settlement under the 2005 Stock Incentive Plan.

How many CLX shares were withheld for taxes on October 5, 2026?

Clorox withheld 692 shares for tax obligations relating to vesting performance stock units and 11,989 shares for tax obligations relating to vesting restricted stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/07/2026 - 04:24 PM Accepted by SEC EDGAR 10/07/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rendle Linda J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/05/2026		A(1)		29,352	A	$80.41	282,488	D
Common Stock	10/05/2026		F(2)		692	D	$80.41	281,796	D
Common Stock	10/05/2026		F(3)		11,989	D	$80.41	269,807(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Settlement of 2023 Performance Unit Grant that vested 10/5/26, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.

2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.

3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.

4. Includes 3679 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

	By Jinho Joo, Attorney-in-Fact	10/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)